Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rtPA) is approved in Europe for use in patients with acute ischaemic stroke who meet strictly defined criteria. IST-3 sought to improve the external validity and precision of the estimates of the overall treatment effects (efficacy an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Innes, Karen, Cohen, Geoff, Whiteley, Will, Perry, David, Soosay, Vera, Buchanan, David, Venables, Graham, Czlonkowska, Anna, Kobayashi, Adam, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme J, Matz, Karl, Brainin, Michael, Ricci, Stefano, Cantisani, Teresa A, Gubitz, Gordon, Phillips, Stephen J, Antonio, Arauz, Correia, Manuel, Lyrer, Phillippe, Kane, Ingrid, Lundstrom, Erik
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Update
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286387/
https://ncbi.nlm.nih.gov/pubmed/22129158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-252
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados